IRBESARTAN HCT ACTAVIS TABLETS 150/12.5MG

Approval Date: Jun 21, 2024
Approval ID: 68c5f8d7096dcf64
Company: TEVA PHARMACEUTICAL HONG KONG O/B TEVA PHARMACEUTICAL HONG KONG LIMITED
Type: Standard

Approval Id: 68c5f8d7096dcf64
Product Name: IRBESARTAN HCT ACTAVIS TABLETS 150/12.5MG
Drug Hk Name: IRBESARTAN HCT ACTAVIS TABLETS 150/12.5MG
Registration Code: HK-63378
Company Name: TEVA PHARMACEUTICAL HONG KONG O/B TEVA PHARMACEUTICAL HONG KONG LIMITED
Company Detail Path: /organization/teva-pharmaceutical-hong-kong-limited
Registration Category: Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement: Prescription only Medicines
Registration Date: 2015-01-05
Company Address: FLAT/RM 2303, 23/F, MIRA PLACE TOWER A, 132 NATHAN ROAD, TSIM SHA TSUI, KOWLOON

Approved

Agency

PPB

Country

🇰🇪

Approval Date

Jun 21, 2024

Approval ID

68c5f8d7096dcf64

Type

Standard